arrow
M

Marilyn James

University of Nottingham
H指数:22
被引数:2,773

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and cost-effectiveness of a standardised diagnostic assessment for children and adolescents with emotional difficulties: the STADIA multi-centre RCT
2025-11-010
PRE
The clinical and cost effectiveness of a STAndardised DIagnostic Assessment for children and adolescents with emotional difficulties: the STADIA multi-centre randomised controlled trial
2025-01-070
OAAI
BRIGhTMIND randomised double-blind controlled trial of connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment resistant depression: protocol
2019-07-010
PREAI
Consensus workshops on the development of an ADHD medication management protocol using QbTest: developing a clinical trial protocol with multidisciplinary stakeholders

关于使用QbTest开发ADHD药物管理协议的共识研讨会: 与多学科利益相关者一起开发临床试验协议

2019-06-185
OAAI
Clinical and economic outcomes of remotely delivered cognitive behaviour therapy versus treatment as usual for repeat unscheduled care users with severe health anxiety: a multicentre randomised controlled trial

远程认知行为疗法与常规治疗对严重健康焦虑的重复计划外护理使用者的临床和经济结果: 一项多中心随机对照试验

2019-01-2347
OAAI
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2018-08-0111
OA
The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial
2018-04-2639
OAAI
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
LANCET
IF88.5
2018-03-01118
OAAI
Baseline characteristics of the 3096 patients recruited into the Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial
2016-11-045
OAAI